Opinions
Jim Cramer - Mad Money
Exact Sciences Corporation
EXAS-Q
BUY
Mar 15, 2021
They produce the screening test to detect early colorectal cancer. This is real, and they have much more in the pipeline. That's why the stock is rising.
$129.460
Stock price when the opinion was issued
medical services
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
BUY
A diagnostics company and a great long-term growth company. They screen for cancers such as colorectal. It struggled last year, then tanked during Covid. Since then, it's made a big comeback, tripling since the March bottom. They're developing their own Covid test. They just announced positive data for their multi-cancer a liquid biopsy test. If it gets approval, it will widely expand their market. The shares are just shy of last year's old-time high. He expects more upside.
medical services